IMMUNOVEDA

Serial Number 98023585
Registration 7420259
700

Registration Progress

Application Filed
Jun 1, 2023
Under Examination
Approved for Publication
Apr 2, 2024
Published for Opposition
Apr 2, 2024
Registered
Jun 18, 2024

Trademark Image

IMMUNOVEDA

Basic Information

Serial Number
98023585
Registration Number
7420259
Filing Date
June 1, 2023
Registration Date
June 18, 2024
Published for Opposition
April 2, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 18, 2024
Registration
Registered
Classes
042

Rights Holder

Genesis Drug, Discovery & Development, LLC

16
Address
Law Department
2439 Kuser Road
Hamilton, NJ 08690

Ownership History

Genesis Drug, Discovery & Development, LLC

Original Applicant
16
Hamilton, NJ

Genesis Drug, Discovery & Development, LLC

Owner at Publication
16
Hamilton, NJ

Genesis Drug, Discovery & Development, LLC

Original Registrant
16
Hamilton, NJ

Legal Representation

Attorney
Christina E. Brule

USPTO Deadlines

Next Deadline
1640 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240618)
Due Date
June 18, 2030
Grace Period Ends
December 18, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

14 events
Date Code Type Description Documents
Jun 18, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jun 18, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 2, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 2, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 13, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 23, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 23, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 15, 2023 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Sep 15, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 15, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 15, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 6, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jul 5, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 5, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Medical research services in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Providing laboratory research services in the field of gene expression, namely, cancer biology
First Use Anywhere: 20201100
First Use in Commerce: 20201100

Additional Information

Design Mark
The mark consists of the word "IMMUNOVEDA", above the letter "I" is a dot; starting from this first dot is a series of dots with each dot getting smaller in size and lighter in contrast to the first dot, and the space between the dots increases as the dots sweep upward in a curve toward the top of the mark, creating a band of dots, reaching an apex whereupon they descend in a curve toward the letter "A", upon reaching the letter "A" in one single dot whereupon they end.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
042